Heart failure Clinical Trials in Bridgeport, CT
As of June 2026, 5 paid clinical trials are recruiting for Heart failure in Bridgeport, Connecticut. Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Bridgeport
Filter results
5 clinical trials for Heart failure
·Clear filters·↓ Download CSVPhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
About research studies in Bridgeport
Bridgeport has approximately 30 recruiting research studies across a wide range of therapeutic areas. Connecticut hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Bridgeport
Researchers run research studies in Bridgeport, CT at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Bridgeport Hospital | Heart Failure, Acute Myocardial Infarction (AMI), Cardiovascular Disease | 8 |
| Hartford HealthCare - Saint Vincent's Medical Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma | 5 |
| New England Research Associates, LLC | Obesity, Overweight | 2 |
| Bridgeport | Hypertension | 1 |
| Bridgeport Hosptial | Cardiovascular Diseases, Hypertension, Vascular Diseases | 1 |
| Cardiology Associates of Fairfield County, P.C | Heart Failure, Heart Failure With Reduced Ejection Fraction | 1 |
| Cardiology Physicians of Fairfield County - Bridgeport | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Family Foot & Ankle Specialists, LLC | Chronic Ulcers, DFU, Diabetic Foot Ulcers (DFU) | 1 |
| Hartford Health Care St. Vincent's Medical Center | Atrial Fibrillation, Stroke | 1 |
| Kailera Clinical Site | Obesity, Overweight | 1 |
| Liberation Programs | Intimate Partner Violence (IPV), Opioid Use Disorder, Post Traumatic Stress Disorder PTSD | 1 |
| Mount Aery Baptist Church | Medication Assisted Treatment, Mental Health Issue, Opioid Use | 1 |
| New England Research Associates | Influenza | 1 |
| New England Research Associates - Bridgeport | Hypothyroidism | 1 |
| Principe of Peace Church | Medication Assisted Treatment, Mental Health Issue, Opioid Use | 1 |
| Saint Vincent's Medical Center (SVMC) | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| St. Vincent (Data Collection Only) | Hematologic Cancers, Solid Tumors | 1 |
| Surgical Center of Connecticut | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Bridgeport (2026)
Recruiting trials in Bridgeport grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cardiovascular (10 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Cancer & tumors (6 active studies)
- Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · Phase 3 · Alliance for Clinical Trials in Oncology
- Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · Phase 2, Phase 3 · National Cancer Institute (NCI)
Diabetes & metabolic (4 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin · Phase 3 · Eli Lilly and Company
- Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes · Phase 3 · Kailera
Mental health & behavior (2 active studies)
Neurology & pain (2 active studies)
- SORE Study: Sitz Baths After Urogynecologic Reconstruction · Yale University
- The CONFORM Pivotal Trial · Conformal Medical, Inc
Vaccines (1 active study)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Common conditions studied in Bridgeport
- Heart Failure (5 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Hypertension (4 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Obesity (3 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Overweight (3 active studies). Recruiting Overweight studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Bridgeport
- Boehringer Ingelheim
- Yale University
- Alliance for Clinical Trials in Oncology
- Eli Lilly and Company
- Novo Nordisk A/S
Local regulations and guidelines
Clinical trials in Connecticut are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Connecticut research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Bridgeport. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Bridgeport
Hipa.ai aggregates every recruiting study in Bridgeport from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Bridgeport?
There are approximately 30 recruiting clinical trials in Bridgeport, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bridgeport pay participants?
Most recruiting trials in Bridgeport compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bridgeport?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bridgeport?
The most common conditions under active study in Bridgeport include Heart Failure (5), Hypertension (4), Obesity (3), Overweight (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bridgeport?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bridgeport on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bridgeport?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bridgeport?
Recruiting research sites in Bridgeport include Bridgeport Hospital, Hartford HealthCare - Saint Vincent's Medical Center, New England Research Associates, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bridgeport right now?
The largest active categories in Bridgeport are Cardiovascular (10), Cancer & tumors (6), Diabetes & metabolic (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.